Stay updated on Risankizumab vs Placebo in Psoriasis in Russia Clinical Trial
Sign up to get notified when there's something new on the Risankizumab vs Placebo in Psoriasis in Russia Clinical Trial page.

Latest updates to the Risankizumab vs Placebo in Psoriasis in Russia Clinical Trial page
- ChecktodayNo Change Detected
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe study record page now displays a 403 Forbidden error, indicating access to the content is blocked. The visible portion shows the site chrome (header/footer) while the actual study details are not accessible.SummaryDifference17%

- Check35 days agoChange Detected- Revision: v3.6.6 is now shown on the page, replacing Revision: v3.6.5. This indicates a small update to the page's template or content rendering without changing the study information.SummaryDifference0.1%

- Check57 days agoChange DetectedA new footer line 'Revision: v3.6.5' has been added. The text items 'clinical study report synopsis', 'AbbVie', 'Helpful Links Provided by', and the previous 'Revision: v3.6.4' have been removed.SummaryDifference0.2%

- Check71 days agoChange DetectedRevision: v3.6.4 replaces the previous Revision: v3.6.3 on the page. This appears to be a backend/UI update and does not modify study data or visible page content.SummaryDifference0.1%

- Check93 days agoChange DetectedThe page's revision label was updated from v3.6.2 to v3.6.3, signaling a small site update. The study details and other content remain unchanged.SummaryDifference0.1%

- Check100 days agoChange DetectedThe page now shows Revision: v3.6.2 instead of v3.6.0, indicating a minor update to the page template. This update does not affect the study details or the information presented to users.SummaryDifference0.1%

Stay in the know with updates to Risankizumab vs Placebo in Psoriasis in Russia Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Risankizumab vs Placebo in Psoriasis in Russia Clinical Trial page.